The hormone insulin rises in the blood after consuming food. Too high of an insulin response may be a sign of dysfunctional metabolism and has also been shown to promote weight gain. Thus, if insulin levels rise too high after a meal it may indicate that someone is metabolically unhealthy or is prone to obesity. […]

Kane Biotech Inc. is a Manitoba based company that provides innovative technologies that breakdown and disperse microbial biofilms. Dispersin B is an enzyme that both inhibits and disperses bacterial biofilms. Kane Biotech Inc. has expressed this enzyme protein in E. coli, with the goal of developing Dispersin B based products. Dispersin B yield and cost […]

Lyme disease is one of the many diseases transmitted by ticks. The rate of these diseases is rapidly increasing in Canada. Diagnosing these diseases is difficult but examination of biopsy, necropsy and autopsy tissue can help to understand the full and varied effects of the disease and ultimately reduce misdiagnoses. Biobanks are required for this […]

Many therapeutic targets are proteins embedded in the membrane that surrounds the cell. Traditionally, such targets present major challenges, because they required the use of detergents to extract them from the membrane and to purify them. Such detergents can cause artefacts, hampering the development of novel therapeutics. Here we will test new methods that get […]

Heterogeneity of cell populations is a common occurrence in bioreactor operations (Lara et al., 2006) and is typically caused by processing of cell cultures in vessels of varying sizes and process conditions and by deficient mixing. Most bioreactor research deals with average conditions of the cell population with respect to quantities such as dissolved oxygen […]

Inflammatory bowel disease (IBD) is a disease with unknown etiology that is characterized by uncontrolled intestinal inflammation and microbial dysbiosis. Qu Biologics’ Site Specific Immunomodulators (SSI) are a platform technology shown to improve the status of people living with IBD (Crohn’s disease and ulcerative colitis), with most of those patients showing clinical improvement also going […]

This project aims at evaluating whether recent results in deep learning models, trained to exploit weak labels (Hwang, 2016) can serve to extract meaningful lesion localizations from image-level labels, either from individual scans or given a (longitudinal) sequence thereof. To this end, we will scale up existing models that have been shown to work on […]

L’industrie avicole représente une force motrice de l’économie canadienne et les antibiotiques ont largement contribué à optimiser cette production. Cependant, le phénomène grandissant de la résistance aux antibiotiques ainsi que les pressions exercées par les gouvernements et consommateurs font en sorte que l’industrie avicole canadienne en est à revoir ses pratiques afin de réduire l’utilisation […]

The analysis of protein-protein interactions is critical for understanding cell growth control, and how aberrant connections contribute to cancer and other diseases. Mass spectrometry is a critical tool in this field, but sample complexity, instrument dynamic range and resolution limit some applications. This project will evaluate the use of the SelexION ion mobility device and […]

By studying protein complexes, scientists gain insight into how cells are regulated and how aberrations in protein-protein interactions cause disease. Mass spectrometry is a technology that allows proteins to be identified and quantified in a systematic and unbiased manner. New technologies from mass spectrometer vendor SCIEX aim to improve the throughput, accuracy and reproducibility of […]

Most red blood cells (RBCs) are stored from 1-6 °C in an additive solution of saline, adenine, glucose, and mannitol for up to 42 days. Cryopreservation of RBCs at -80 ºC in 40% glycerol can prolong their shelf life to at least ten years; however, the process to remove glycerol prior to transfusion is time-consuming […]

The aim of this project is to research and develop a new DICOM modality for the optical coherence tomography images obtained by Perimeter’s Optical Tissue Imaging (OTISTM) device. Following the creation of a suitable modality, a novel solution for transfer to and integration with the PACS servers utilized by current Perimeter customers will also be […]